Pubblicazioni

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice

2020 - DIABETES, OBESITY AND METABOLISM
Sesti, G.; Bardtrum, L.; Dagdelen, S.; Halladin, N.; Haluzik, M.; Orsy, P.; Rodriguez, M.; Aroda, V. R.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma